1448347-64-5

Upstream product

• 1448348-39-7 5-((2S)-N-(1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano pyridin-2-yl)-5-oxopyrrolidine-2-carboxamido)isophthalamide 
• 96042-30-7 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 
• 1029720-19-1 tert-butyl (3,3-difluorocyclobutyl)carbamate 
• 1355328-30-1 N-(3,3-difluorocyclobutyl)formamide 
• 1355328-31-2 1,1-difluoro-3-isocyanocyclobutane 
• 28321-49-5 1-aminobenzene-3,5-dicarboxylic acid diamide 
• 618-88-2 5-nitrobenzene-1,3-dicarboxylic acid 
• 13438-30-7 5-nitro-1,3-benzenedicarbonylchloride 
• 38177-07-0 5-nitro-1,3-benzenedicarboxamide 
• 154748-49-9 3-(tert-butyloxycarbonylamino)cyclobutan-1-one 

Relevant academic research and scientific papers

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF

Provided are therapeutically active compounds and the use in manufacture of medicaments for treating a cancer characterized by the presence of a mutant allele of IDH1.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.